Dr. Druckmann's lab is interested in elucidating the relationship between behavior and the underlying neuronal circuit structure and neural population dynamics.

Dr. Mahajan's laboratory's focus is the development of personalized medicine for eye diseases through translation of our discoveries in proteomics, genomics, and phenomics in humans, mice and tissue culture models.

Dr. van Rechem's long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved.

Dr. Bintu's lab performs single-cell measurements of chromatin and gene regulation dynamics, and uses these data to develop predictive models of basic biological processes and improve mammalian cell engineering.

The O'Connell lab studies evolutionary innovations in physiology and behavior, from molecules to organisms to ecosystems.

Dr. Poldrack's lab uses the tools of cognitive neuroscience to understand how decision making, executive control, and learning and memory are implemented in the human brain.

Dr. Wu spearheads the oculoplastic research program at Stanford University and is developing cutting edge stem cell and regenerative medicine treatments for vision loss and other eye diseases.

Dr. Leng has an active program in imaging informatics and deep learning to perform big data analyses of retinal scans to identify patients who are at risk for retinal disease deterioration, with the end goal of earlier detection and rapid treatment to maximize visual outcomes; and is considered a leading expert optical coherence tomography (OCT), a non-invasive and non-contact imaging technique for the retina.

Dr. Fischbach's laboratory uses a combination of genomics and chemistry to identify and characterize small molecules from microbes, with an emphasis on the human microbiome.

The Myung Research Group is a translational laboratory focused on two areas of clinical need: ophthalmic regenerative medicine through tissue engineering and drug delivery; and global health through mobile technologies and telemedicine.